DIFFMUNIZE
Third Extension - Granted
Status timeline
- 17 Sep 2024Application filedNew Application Entered
- 25 Nov 2024Assigned to an examining attorneyAssigned To Examiner
- 30 Nov 2024Approved for publicationApproved For Pub - Principal Register
- 24 Dec 2024Published for oppositionPublished For Opposition
- 18 Feb 2025Notice of allowance issued — statement of use requiredNoa E-Mailed - Sou Required From Applicant
- 22 Jul 2025Statement-of-use extension 1 grantedSou Extension 1 Granted
- 5 Dec 2025Statement-of-use extension 2 grantedSou Extension 2 Granted
- 29 Jul 2026Statement-of-use extension 3 grantedSou Extension 3 Granted
All 32 USPTO events
| 2026-07-30 | Notice Of Approval Of Extension Request E-Mailed |
| 2026-07-29 | Sou Teas Extension Received |
| 2026-07-29 | Sou Extension 3 Filed |
| 2026-07-29 | Sou Extension 3 Granted |
| 2026-05-12 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-05-12 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-05-12 | Teas Change Of Correspondence Received |
| 2026-05-12 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2026-01-30 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2026-01-30 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2026-01-30 | Teas Change Of Correspondence Received |
| 2026-01-30 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2025-12-06 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-12-05 | Sou Teas Extension Received |
| 2025-12-05 | Sou Extension 2 Filed |
| 2025-12-05 | Sou Extension 2 Granted |
| 2025-12-04 | Teas Revoke/App/Change Addr Of Atty/Dom Rep Received |
| 2025-12-04 | Attorney/Dom.rep.revoked And/Or Appointed |
| 2025-12-04 | Teas Change Of Correspondence Received |
| 2025-12-04 | Teas Withdrawal Of Attorney Received-Firm Retains |
| 2025-07-23 | Notice Of Approval Of Extension Request E-Mailed |
| 2025-07-22 | Sou Teas Extension Received |
| 2025-07-22 | Sou Extension 1 Filed |
| 2025-07-22 | Sou Extension 1 Granted |
| 2025-02-18 | Noa E-Mailed - Sou Required From Applicant |
| 2024-12-24 | Published For Opposition |
| 2024-12-24 | Official Gazette Publication Confirmation E-Mailed |
| 2024-12-18 | Notification Of Notice Of Publication E-Mailed |
| 2024-11-30 | Approved For Pub - Principal Register |
| 2024-11-25 | Assigned To Examiner |
| 2024-09-17 | New Application Entered |
| 2024-09-17 | New Application Office Supplied Data Entered |
Goods & services
Class 5 Pharmaceuticals & supplements
Pharmaceutical preparations for the treatment of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; pharmaceutical preparations for the treatment of blood disorders, bone growth disorders, skin disorders, arthritis, cancer, hypertension, pain, stroke, obesity and diabetes; pharmaceutical preparations, namely, anti-infective preparations, medicated dermatological preparations and smoking cessation preparations; vaccines for human use
Source & freshness
Source: USPTO Trademark Applications bulk data. This record was last updated by the USPTO file dated 30 Jul 2026; the index was built on 20 Nov 2026 and covers USPTO data through 31 Aug 2026. Open the official USPTO record (TSDR) → If the two differ, the USPTO record is correct.